Sujata Patil

4.3k total citations
104 papers, 2.5k citations indexed

About

Sujata Patil is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sujata Patil has authored 104 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 45 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Sujata Patil's work include Renal cell carcinoma treatment (44 papers), Cancer Genomics and Diagnostics (25 papers) and Renal and related cancers (24 papers). Sujata Patil is often cited by papers focused on Renal cell carcinoma treatment (44 papers), Cancer Genomics and Diagnostics (25 papers) and Renal and related cancers (24 papers). Sujata Patil collaborates with scholars based in United States, France and India. Sujata Patil's co-authors include Robert J. Motzer, Darren R. Feldman, Nicole Ishill, Martin H. Voss, Michelle S. Ginsberg, Ana M. Molina, George J. Bosl, Michael Baum, Patricia Fischer and Chung‐Han Lee and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer.

In The Last Decade

Sujata Patil

97 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sujata Patil United States 29 1.4k 1.1k 788 682 661 104 2.5k
Giacomo Cartenì Italy 27 1.4k 1.0× 648 0.6× 1.7k 2.2× 521 0.8× 864 1.3× 110 3.2k
Hyo Song Kim South Korea 34 2.0k 1.5× 875 0.8× 1.8k 2.3× 536 0.8× 809 1.2× 182 3.7k
Francesca Sanguedolce Italy 28 744 0.5× 700 0.6× 547 0.7× 338 0.5× 701 1.1× 167 2.3k
Federica Grosso Italy 33 3.0k 2.2× 642 0.6× 1.8k 2.3× 418 0.6× 535 0.8× 158 4.4k
Feng‐Hua Wang China 31 861 0.6× 872 0.8× 1.5k 1.9× 822 1.2× 637 1.0× 126 2.9k
Sadhana Kannan India 24 780 0.6× 694 0.6× 512 0.6× 384 0.6× 509 0.8× 145 2.6k
Veronica Mollica Italy 29 1.6k 1.1× 853 0.8× 1.5k 1.9× 620 0.9× 691 1.0× 155 3.0k
Dirk Klingbiel Switzerland 28 1.0k 0.7× 753 0.7× 2.5k 3.2× 641 0.9× 552 0.8× 86 3.8k
Jean‐Pierre Lotz France 26 699 0.5× 347 0.3× 1.6k 2.0× 447 0.7× 698 1.1× 119 2.8k
Cristine Allmer United States 23 599 0.4× 757 0.7× 1.4k 1.8× 259 0.4× 693 1.0× 84 2.9k

Countries citing papers authored by Sujata Patil

Since Specialization
Citations

This map shows the geographic impact of Sujata Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujata Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujata Patil more than expected).

Fields of papers citing papers by Sujata Patil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujata Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujata Patil. The network helps show where Sujata Patil may publish in the future.

Co-authorship network of co-authors of Sujata Patil

This figure shows the co-authorship network connecting the top 25 collaborators of Sujata Patil. A scholar is included among the top collaborators of Sujata Patil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujata Patil. Sujata Patil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yehia, Lamis, et al.. (2025). Extended spectrum of cancers in PTEN hamartoma tumor syndrome. npj Precision Oncology. 9(1). 61–61.
3.
Patil, Sujata, et al.. (2024). Practice changes and infant health risks during the 2022 infant formula shortage: Results of a US healthcare provider survey. Nutrition in Clinical Practice. 40(2). 475–483. 1 indexed citations
4.
Knežević, Andrea, Sujata Patil, Joel Sheinfeld, et al.. (2024). Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease. Journal of Clinical Oncology. 42(26). 3130–3139. 4 indexed citations
5.
Dezem, Felipe Segato, et al.. (2023). Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer. Cancer Medicine. 12(9). 10647–10659. 7 indexed citations
6.
Yehia, Lamis, Carol A. Burke, Steven C. Campbell, et al.. (2023). Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants. JAMA Network Open. 6(4). e239705–e239705. 20 indexed citations
7.
Yehia, Lamis, Jin Jiang, Carole Macaron, et al.. (2023). Longitudinal analysis of cancer risk in children and adults with germline PTEN variants. Yearbook of pediatric endocrinology. 8 indexed citations
8.
Ged, Yasser, Alejandro Sánchez, Sujata Patil, et al.. (2022). Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade. Clinical Cancer Research. 28(23). 5180–5189. 20 indexed citations
9.
Feldman, Darren R., Yasser Ged, Chung‐Han Lee, et al.. (2020). Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. Cancer. 126(24). 5247–5255. 27 indexed citations
10.
Sánchez, Alejandro, Helena Furberg, Fengshen Kuo, et al.. (2019). Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. The Lancet Oncology. 21(2). 283–293. 127 indexed citations
11.
Bastos, Diogo Assed, Ana M. Molina, Vaios Hatzoglou, et al.. (2014). Safety and Efficacy of Targeted Therapy for Renal Cell Carcinoma With Brain Metastasis. Clinical Genitourinary Cancer. 13(1). 59–66. 30 indexed citations
12.
Feldman, Darren R., Walter M. Stadler, Leonard J. Appleman, et al.. (2014). Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR).. Journal of Clinical Oncology. 32(4_suppl). 364–364. 2 indexed citations
13.
Patil, Sujata, et al.. (2014). Analysis of human papilloma virus in oral squamous cell carcinoma using p16: An immunohistochemical study. Journal of International Society of Preventive and Community Dentistry. 4(1). 61–61. 23 indexed citations
14.
Feldman, Darren R., Martin H. Voss, Erin Jacobsen, et al.. (2013). Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older. Cancer. 119(14). 2574–2581. 26 indexed citations
15.
Morris, Patrick G., Conleth G. Murphy, Divya Mallam, et al.. (2012). Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer. The Breast Journal. 18(4). 345–350. 32 indexed citations
16.
Patil, Sujata, Robert A. Figlin, Thomas E. Hutson, et al.. (2012). Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α. British Journal of Cancer. 106(10). 1587–1590. 24 indexed citations
17.
Feldman, Darren R., Joel Sheinfeld, Dean F. Bajorin, et al.. (2010). TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis. Journal of Clinical Oncology. 28(10). 1706–1713. 147 indexed citations
18.
Patil, Sujata, Nicole Ishill, John DeLuca, & Robert J. Motzer. (2009). Stage migration and increasing proportion of favorable‐prognosis metastatic renal cell carcinoma patients. Cancer. 116(2). 347–354. 41 indexed citations
19.
Feldman, Darren R., Nicole Ishill, Stefan Turkula, et al.. (2008). Infectious Complications from High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Germ Cell Tumors. Biology of Blood and Marrow Transplantation. 14(5). 595–600. 4 indexed citations
20.
Feldman, Darren R., G. Varuni Kondagunta, Lawrence H. Schwartz, et al.. (2008). Phase II Trial of Pegylated Interferon-α2b in Patients with Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 6(1). 25–30. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giacomo Cartenì Breakdown of academic impact, for papers by Hyo Song Kim Breakdown of academic impact, for papers by Francesca Sanguedolce Breakdown of academic impact, for papers by Federica Grosso Breakdown of academic impact, for papers by Feng‐Hua Wang Breakdown of academic impact, for papers by Sadhana Kannan Breakdown of academic impact, for papers by Veronica Mollica Breakdown of academic impact, for papers by Dirk Klingbiel Breakdown of academic impact, for papers by Jean‐Pierre Lotz Breakdown of academic impact, for papers by Cristine Allmer
Rankless by CCL
2026